Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow was −$57.2M: capital expenditures were more than operating cash flow. Cash rose by $11.8M. What is a cash flow statement?
- Free cash flow
- −$57.2M −16.4% of operating cash flow
- Returned to shareholders
- $289.5M
- Debt, net
- $107.7M borrowed
- Change in cash
- +$11.8M over the period
| Operating cash flow | 348.6 |
|---|---|
| Capital expenditures | −405.8 |
| Free cash flow | −57.2 |
| Into investments, net | −1.3 |
| Dividends | −289.5 |
| Shares issued, net | +227.8 |
| Debt raised, net | +107.7 |
| Other | +24.3 |
| Change in cash | 11.8 |
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $176M | $136M | $361M | $372M | $355M | $356M | $316M | $301M | $311M | $349M |
| Capex | −$57M | −$277M | $93M | $252M | −$124M | −$41M | −$59M | $84M | −$95M | −$406M |
| Free cash flow | $119M | −$141M | $454M | $625M | $231M | $315M | $256M | $385M | $215M | −$57M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
70.21 | 158.37 | 279.12 | 69.02 | 138.42 | (113.26) | (77.60) | 13.76 | 126.71 | 155.51 |
Depreciation & Amortization |
68.47 | 113.88 | 191.38 | 181.55 | 176.74 | 178.99 | 187.78 | 183.09 | 169.62 | 187.00 |
Non Cash Items (Other) |
32.28 | (48.45) | (91.41) | 145.42 | 42.44 | 267.95 | 225.25 | 106.46 | 36.76 | 15.96 |
Accounts Receivable Change |
(2.34) | (16.81) | (6.75) | (9.64) | (6.40) | 8.22 | (6.44) | (11.08) | (15.46) | (11.45) |
Change in payables and accrued liability |
7.31 | (71.20) | (11.74) | (13.87) | 3.66 | 14.48 | (13.25) | 8.34 | (7.09) | 1.60 |
Operating Cash Flow |
175.93 | 135.79 | 360.59 | 372.48 | 354.85 | 356.39 | 315.73 | 300.57 | 310.54 | 348.61 |
Capital expenditures |
(56.58) | (276.62) | 93.35 | 252.46 | (123.55) | (41.38) | (59.37) | 84.24 | (95.14) | (405.82) |
Net Aquisitions |
— | 77.86 | — | — | — | — | — | — | — | — |
Long-Term Investments Change (Net) |
(7.35) | (2.75) | (359.77) | — | (20.07) | (7.77) | (150.93) | (16.26) | (4.09) | (1.25) |
Other investing activities |
206.29 | 18.95 | 7.93 | 10.38 | 7.17 | (287.05) | (5.94) | 35.15 | (9.77) | 29.11 |
Investing cash flow |
142.36 | (182.56) | (258.49) | 262.84 | (136.45) | (336.20) | (216.25) | 103.13 | (109.00) | (377.96) |
Repayment/Issuance of Debt (Net) |
(174.41) | 429.86 | (157.34) | (833.66) | (3.07) | 23.86 | 122.78 | (94.13) | 12.56 | 107.72 |
Equity Repurchase (Common, Net) |
(1.29) | 366.80 | (0.50) | 549.33 | 80.09 | 308.71 | (4.81) | (2.68) | 86.12 | 227.78 |
Equity Repurchase (Preffered, Net) |
— | — | (143.75) | — | — | — | — | — | — | — |
Dividends Paid (Total) |
(119.26) | (182.09) | (325.22) | (335.43) | (278.30) | (262.92) | (277.16) | (277.45) | (280.15) | (289.50) |
Other financial activities |
(5.94) | (15.75) | (2.54) | (26.42) | (0.83) | (39.51) | (2.52) | (36.04) | (0.09) | (5.24) |
Financing cash flow |
(300.90) | 598.82 | (629.34) | (646.18) | (202.11) | 30.14 | (161.71) | (410.30) | (181.56) | 40.76 |
Exchange Rate Adjustment |
0.03 | 0.74 | (0.54) | 0.35 | 0.09 | 0.03 | 0.27 | (0.61) | (0.36) | 0.39 |
Change in Cash |
17.42 | 552.78 | (527.79) | (10.51) | 16.38 | 50.36 | (61.95) | (7.21) | 19.62 | 11.80 |
Beginning Cash |
17.25 | 34.67 | 587.45 | 59.66 | 49.14 | 65.52 | 115.89 | 53.93 | 46.72 | 66.34 |
Ending Cash |
34.67 | 587.45 | 59.66 | 49.14 | 65.52 | 115.89 | 53.93 | 46.72 | 66.34 | 78.14 |
Stock Based Compensation |
7.50 | 8.36 | 7.65 | 9.82 | 7.91 | 7.91 | 7.45 | 7.92 | 8.99 | 11.36 |
Dividends Paid (Common) |
(119.26) | (182.09) | (325.22) | (335.43) | (278.30) | (262.92) | (277.16) | (277.45) | (280.15) | (289.50) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
4.97 | (88.01) | (18.50) | (23.51) | (2.74) | 22.70 | (19.69) | (2.73) | (22.55) | (9.85) |
Investments Change (Net) |
(7.35) | (2.75) | (359.77) | — | (20.07) | (7.77) | (150.93) | (16.26) | (4.09) | (1.25) |
Issuance/Purchase of Shares |
(1.29) | 366.80 | (144.25) | 549.33 | 80.09 | 308.71 | (4.81) | (2.68) | 86.12 | 227.78 |
| Other line items | ||||||||||
Revenue per Employee |
18.61 | 6.69 | 20.11 | 19.46 | 15.75 | 13.56 | 14.88 | 13.49 | 14.06 | 13.36 |